Steven Cohen’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.03M Buy
11,900
+11,600
+3,867% +$965K ﹤0.01% 2774
2026
Q2
$20.2K Sell
300
-24,500
-99% -$1.63M ﹤0.01% 3872
2026
Q1
$1.56M Buy
24,800
+8,000
+48% +$557K ﹤0.01% 2472
2025
Q4
$1.12M Buy
16,800
+11,700
+229% +$756K ﹤0.01% 2813
2025
Q3
$343K Sell
5,100
-94,900
-95% -$7.51M ﹤0.01% 2033
2025
Q2
$8.73M Hold
100,000
– – 0.02% 786
2025
Q1
$6.83M Buy
+100,000
New +$8.16M 0.02% 819
2023
Q3
– Sell
-26,200
Closed -$3.37M – 2557
2023
Q2
$3.37M Buy
+26,200
New +$3.17M 0.01% 936

Other funds holding DXCM

Steven Cohen's DXCM Position: Q3 2026 in Review

Steven Cohen sold out of DexCom (DXCM) in Q3 2026, closing a stake of 282,840 shares — an estimated $23.5M sold.

Steven Cohen first reported a position in DXCM in Q4 2015 and held it in 34 quarters. The position peaked at $181M in Q1 2023. 1,056 funds tracked by Wall St. Rank hold DXCM as of Q3 2026.

  • Steven Cohen reported no remaining DexCom position as of Q3 2026 after selling out during the quarter.
  • Steven Cohen sold 282,840 DexCom shares in Q3 2026, an estimated $23.5M.
  • Steven Cohen first reported a position in DexCom in Q4 2015 and held it in 34 quarters.
  • Steven Cohen's DexCom position peaked at $181M in Q1 2023.
  • 1,056 funds tracked by Wall St. Rank held DexCom as of Q3 2026.

Based on Point72 Asset Management's 13F filing for Q3 2026, filed 16 Nov 2026.